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a b s t r a c t
Background: Obstructive sleep apnea (OSA) is one of the possible causes of atrial ﬁbrillation (AF). Continuous
positive airway pressure (CPAP) therapy may lower the recurrence rate of AF after cardioversion to normal
sinus rhythm. We report a case of AF caused by OSA and successfully converted by CPAP therapy.
Case: A 65-year-old man presented with AF of unidentiﬁed causes. After severe OSA was diagnosed, he was
treated with CPAP for 2 months and his cardiac rhythm returned to sinus rhythmwithout any antiarrhythmic
drugs or cardioversion.
Conclusion: AF caused by OSA may be converted to sinus rhythm by CPAP treatment.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Atrial ﬁbrillation (AF) is a common cardiac arrhythmia andmay be
caused by obstructive sleep apnea (OSA). A previous report showed
that AF occurred in 4.8% of the sleep-disordered breathing (SDB)
group (N¼228), whereas only 0.9% of those without SDB presented
with AF (p¼0.003) [1]. Other common causes of AF include
hyperthyroidism, hypertension, and valvular heart disease, particu-
larly mitral stenosis [2]. AF can be a contributing factor for various
diseases such as cerebral or systemic embolism [3]. Conversion of AF
is crucial to reduce cardiovascular morbidity and mortality [4,5].
OSA is a risk factor for hypertension and stroke in particular
[6,7]. Continuous positive airway pressure (CPAP) treatment
reduces deaths and cardiovascular events, and improves hyperten-
sion control [8,9]. The role of CPAP therapy on the treatment of
cardiac arrhythmia is still limited. Here, we reported a case of OSA-
induced AF and successful AF conversion by CPAP therapy.
2. Case history
A 65-year-old Thai man presented with dizziness. His physical
examination was unremarkable except for an irregular pulse. His
electrocardiography (EKG) result was compatible with AF (Fig. 1). He
underwent laboratory examinations for causes of AF, including
echocardiography (Table 1) and thyroid function test. The left atrium
(LA) size was 32 mm. All investigations were normal. He was sent to
a sleep clinic because of a history of snoring, daytime somnolence
(Epworth Sleepiness Scale score of 18/24), morning headache, and AF.
Physical examination revealed a body mass index of 30 kg/m2, neck
circumference of 42 cm, Mallampati class 4, no tonsillar enlargement,
no retrognathia, and no torus. His sleep was monitored using a
portable monitoring device (Embletta)s. The apnea-hypopnea index
(AHI) was 63.6 times/h (supine AHI, 64.5 h1; non-supine AHI,
63.5 h1). Details of AHI values are provided in Table 2. Other
polysomnographic data were as follows:
Total recording time: 8 h 30 min (510 min).
Position: supine 81.9 min (16.4%), non-supine 417.8 min (83.6%);
upright time: 2.4 min (0.5%); movement time: 8.0 min (1.6%).
Oxygen saturation: mean oxygen saturation, 92.4%; oxygen
desaturation events (OD), 162 (19.4 h1); lowest oxygen satura-
tion, 83.0%; oxygen saturation o90%, 60.4 min (13.4%).
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Snoring time: 275.4 min (55.1%), number of snoring episodes:
355, mean snoring episode duration: 0.8 min, longest snoring
episode: 10.2 min.
Plethysmogram: autonomic arousal 150 times (18.0 h1).
Heart rate (HR): total mean HR, 59.8 (53–121) bpm; supine HR,
59.8 (53–71) bpm; non-supine HR, 59.8 (54–121).
CPAP therapy was introduced, and treatment was successful. A
CPAP pressure of 10 cm H2O reduced the AHI to 3.2 h1. The
patient had good compliance with CPAP therapy and reported
refreshed sleep. At the 2 months follow-up examination, his pulse
rate became regular with an EKG ﬁnding of a normal sinus rhythm
(Fig. 2). Unfortunately, he developed left facial palsy due to
squamous cell carcinoma of the inner ear 6 months later. He
stopped complying with CPAP therapy owing to poor mask ﬁtting.
His cardiac rhythm returned to AF at 2 months after he stopped
using CPAP. He died of brain metastasis.
3. Discussion
The condition of this patient was diagnosed as OSA-induced AF
because no other possible cause was identiﬁed. OSA has been
shown to be independently associated with AF development [10].
The prevalence rate of OSA-induced AF may be high as 50% [2].
There are several underlying mechanisms. Intermittent desatura-
tion at night is the main mechanism of cardiac arrhythmia caused
by OSA [1,11]. Nighttime hypoxemia from OSA causes atrial
remodeling and dilatation, conduction abnormalities, vagal tone
hyperfunction, pulmonary vasoconstriction/hypertension, or
increase in inﬂammatory markers [11–16].
This case shows that effective CPAP treatment with good
compliance may convert AF to normal sinus rhythm. CPAP therapy
resolves all underlying mechanisms of AF induced by OSA. To our
knowledge, there is no previous report on using CPAP to convert
the AF cardiac rhythm to sinus rhythm in an OSA patient, without
cardioversion or antiarrhythmic drugs. Previously, CPAP therapy
was shown to reduce the recurrence rate of AF after successful
cardioversion to sinus rhythm at the 12 months follow-up exam-
ination [17]. Unfortunately, the present patient was able to comply
with the CPAP therapy for only a short period. Therefore, the long-
term effects of CPAP therapy on cardiac arrhythmia were not
evaluated in this patient.
Although attended polysomnography, which allows evaluation
of sleep stages, was not performed in this patient, the portable
sleep study was approved for the diagnosis of OSA in patients at
risk [18,19]. Pro-brain natriuretic peptide and high-sensitivity
C-reactive protein levels were not measured because of the normal
echocardiogram and the absence of clinical features of heart
failure, coronary artery disease, or other structural heart diseases.
We believed that the AF in this patient was persistent and
converted by CPAP therapy. The clinical symptoms of OSA and
palpitations were also improved after CPAP therapy without any
other treatments for AF. When the patient quit CPAP therapy, the
AF recurred for 41 month, suggesting persistent AF. Therefore,
CPAP therapy may convert AF to sinus rhythm in an OSA patient if
Fig. 1. Electrocardiogram showing atrial ﬁbrillation before continuous positive airway pressure treatment.
Table 1
Echocardiographic ﬁndings by M-mode.
Variables Values
Interventricular septal diameter, diastolic 14.00 mm
Left ventricular end diastolic diameter 47.00 mm
Posterior wall thickness diameter, diastolic 10.00 mm
Interventricular septal diameter, systolic 18.00 mm
Left ventricular end systolic diameter 23.00 mm
Posterior wall thickness, systolic 17.00 mm
Left ventricular mass 215.32 g
Left ventricular mass index 107.12 g/m2
Relative wall thickness 0.43
End diastolic volume (Teich) 102.36 mL
End systolic volume (Teich) 18.00 mL
Ejection fraction (Teich) 82.42%
Aorta (AO) 34.00 mm
Left atrium (LA) 32.00 mm
LA/AO 0.94
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the LA size is still normal [20]. An LA size of o40 mm is considered
normal.
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Fig. 2. Electrocardiogram showing sinus rhythm after continuous positive airway pressure treatment.
Table 2
Apnea/hypopnea index (AHI) details (sleep time: 499.8 min).
Factors Number % AHI/h Supine AHI/h Non-supine AHI/h Mean duration (s) Longest duration (s)
Apnea 498 94.0 59.8 52.0 61.3 23.9 107.9
Obstructive apnea 468 88.3 56.2 46.2 58.2 23.7 107.9
Central apnea 1 0.2 0.1 0 0.1 18.4 18.4
Mixed apnea 28 5.3 3.4 12.5 2.9 28.1 67.8
Hypopnea 32 6.0 3.8 12.5 2.2 17.5 69.5
Total 530 63.6 64.5 63.5 23.5 107.9
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